United Kingdom · Question · Written question
UIN 22202
Semaglutide: Diabetes
Original
Introduced
16 April 2024
Last action
22 April 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
22 April 2024
Summary
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of the guidance submitted to medical professions on the prescription of semaglutide on the availability of that drug for people suffering from t
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
16 April 2024
Written question
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of the guidance submitted to medical professions on the prescription of semaglutide on the availability of that drug for people suffering from t
Source: Commons
22 April 2024
Answer
The Department has worked intensively with industry to seek commitments from them to address issues with the supply of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), including semaglutide, to expedite deliveries and boost supplies. As a result, th...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-04-16/22202
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1701460
- uk · wq-1701460 · source updated 22 April 2024